Skip to main content

En Carta Diagnostics

Paris, France

En Carta Diagnostics is a state-of-the-art molecular testing platform.

$1.6M raised
May 2024
Pre-Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about En Carta Diagnostics

How much funding has En Carta Diagnostics raised?
En Carta Diagnostics has raised $1.6M in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2024.
Who are En Carta Diagnostics's investors?
En Carta Diagnostics's investors include CentraleSupélec Venture.
Where is En Carta Diagnostics headquartered?
En Carta Diagnostics is headquartered in Paris, France.
What does En Carta Diagnostics do?
En Carta Diagnostics is a state-of-the-art molecular testing platform.
What stage is En Carta Diagnostics at?
En Carta Diagnostics is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"En Carta Diagnostics — Funding & Investors." VCBacked, May 22, 2024, https://www.vcbacked.co/company/en-carta-diagnostics. Accessed July 2, 2026.
APA
VCBacked. (2024). En Carta Diagnostics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/en-carta-diagnostics
Wikipedia (cite web)
{{cite web |title=En Carta Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/en-carta-diagnostics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .